Enhanced recovery after cesarean delivery.
Unyime Ituk, Ashraf S Habib
https://pubmed.ncbi.nlm.nih.gov/29770203Actively Recruiting
Led by Okan University · Updated on 2026-04-28
1
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are evaluating the impact of the Enhanced Recovery After Cesarean (ERAS) protocol compared with standard perioperative care on mother-infant and father-infant bonding in women undergoing cesarean delivery. This multicenter, randomized controlled trial aims to assess whether the ERAS protocol can improve early emotional bonding, maternal mental health, breastfeeding initiation, and neonatal outcomes. The study is designed to provide high-quality evidence on psychosocial and clinical benefits of ERAS in cesarean deliveries, an area with limited previous research, especially regarding father-infant bonding. Participants will be randomly assigned to either the ERAS protocol group or the standard care group. The ERAS protocol includes preoperative education and anxiety reduction, multimodal opioid-sparing analgesia during surgery, early oral intake, early mobilization, early removal of urinary catheter, and encouragement of skin-to-skin contact and early breastfeeding with active father involvement. The standard care group will receive routine cesarean perioperative care without these enhancements. The study begins as a single-center trial and will expand to multiple centers once prepared. Participants will be assessed multiple times after cesarean delivery: at 2 hours, 24 hours, 4 days, and 7 days postpartum. Researchers will collect data on mother-infant and father-infant bonding using validated questionnaires, maternal depression scores, breastfeeding initiation times, neonatal intensive care needs, and maternal clinical recovery measures. Outcome assessors and data analysts will remain blinded to treatment allocation to reduce bias. The total target sample size is 300 participants across centers, with an initial 100 participants at the first site.
CONDITIONS
The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlled Clinical Trial.
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Hospital stay until discharge, typically several days postpartum
Participants undergo cesarean delivery and receive either the Enhanced Recovery After Cesarean (ERAS) protocol or standard perioperative care. The ERAS protocol includes preoperative education, multimodal analgesia, early oral intake, early mobilization, early removal of urinary catheter, skin-to-skin contact, early breastfeeding initiation, and involvement of fathers in postpartum care. Standard care follows routine hospital practices without these specific interventions.
1 hospitalization period including delivery and immediate postpartum care
Duration - 7 days postpartum
Participants complete follow-up assessments to evaluate mother-infant and father-infant bonding, maternal postpartum depression, breastfeeding success, and neonatal outcomes at multiple time points after delivery.
Assessments at 2 hours, 24 hours, Day 4, and Day 7 postpartum
Total: 1 location
1
Istanbul Okan University Hospital
Istanbul, Turkey (Türkiye), 34947
Actively Recruiting
G
Gökçenur Karakelleoğlu, Assist Prof
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Unyime Ituk, Ashraf S Habib
https://pubmed.ncbi.nlm.nih.gov/29770203Miray Gözde Özdemir, Berrin Gunaydin, Merih Bayram...
https://pubmed.ncbi.nlm.nih.gov/40301800Ann-Marie Widström, Kajsa Brimdyr, Kristin Svensson...
https://pubmed.ncbi.nlm.nih.gov/30762247Ann Bigelow, Michelle Power, Janis MacLellan-Peters...
https://pubmed.ncbi.nlm.nih.gov/22537390